克莱瑞恩(CLSN)

1.96 0.00 0.0%

今开:0.0昨收:1.96
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:1.3913532E7

克莱瑞恩的热门讨论

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:48

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015061  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:36

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015057  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:57

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015072  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:57

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015076  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:51

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015068  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:51

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015065  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:42

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015059  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:51

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015070  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 04:57

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015074  Size: 5 KB 网页链接查看全文

持股变动声明

克莱瑞恩(CLSN)2022-06-16 05:03

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015078  Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

克莱瑞恩的新闻

抗癌药公司克莱瑞恩盘前涨近70%

抗癌药公司克莱瑞恩盘前涨近70%,报价3.2美元/股。 抗癌药公司克莱瑞恩盘前涨近70%,报价3.2美元/股。 网页链接

克莱瑞恩盘前拉涨超40%

【克莱瑞恩盘前拉涨超40%】抗癌药公司克莱瑞恩盘前拉涨超40%,其癌症治疗药物获得FDA快速批准。(智通财经网) 抗癌药公司克莱瑞恩盘前拉涨超40%,其癌症治疗药物获得FDA快速批准。 网页链接

克莱瑞恩的公告

当期报告

$克莱瑞恩(CLSN)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-22-026238  Act: 34  Size: 1 MB 网页链接

员工持股计划

$克莱瑞恩(CLSN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-22-023028  Act: 33  Size: 155 KB 网页链接

当期报告

$克莱瑞恩(CLSN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-22-022594  Act: 34  Size: 369 KB 网页链接

季度财报

$克莱瑞恩(CLSN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-22-022599  Act: 34  Size: 5 MB 网页链接

首次持股声明

$克莱瑞恩(CLSN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-22-016570  Size: 6 KB 网页链接

持股变动声明

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-016571  Size: 7 KB 网页链接

当期报告

$克莱瑞恩(CLSN)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001493152-22-019765  Act: 34  Size: 670 KB 网页链接

持股变动声明

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015078  Size: 5 KB 网页链接

持股变动声明

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015072  Size: 5 KB 网页链接

持股变动声明

$克莱瑞恩(CLSN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-015074  Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44